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Spatial regulation of mTORC1 signalling: beyond the Rag GTPases 
Bernadette Carroll1 




The mechanistic (or mammalian) Target of Rapamycin Complex 1 (mTORC1) is a central 
regulator of cell growth and metabolism. By integrating mitogenic signals, mTORC1-
dependent phosphorylation of substrates dictates the balance between anabolic, pro-
growth and catabolic, recycling processes in the cell. The discovery that amino acids 
activate mTORC1 by promoting its translocation to the lysosome was a fundamental 
advance in the understanding of mTORC1 signalling. It has since become clear that the 
lysosome-cytoplasm shuttling of mTORC1 represents just one layer of spatial control 
of this signalling pathway. This review will focus on exploring the subcellular 
localisation of mTORC1 and its regulators to multiple sites within the cell. We will 
discuss how these spatially distinct regions such as endoplasmic reticulum, plasma 
membrane and the endosomal pathway co-operate to transduce nutrient availability to 
mTORC1, allowing for tight control of cell growth. 
Keywords: Rheb, autophagy, lysosome, trafficking, endosome, amino acids, endoplasmic 
reticulum, Golgi 
1. Introduction: 
The mechanistic target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine 
kinase that forms the catalytic subunit of two spatially, structurally and functionally distinct 
complexes. mTOR in complex with Raptor, mLst8, DEPTOR and PRAS40 constitutes mTOR 
complex 1 (mTORC1), while mTOR complex 2 (mTORC2) is composed of mLst8, Rictor and 
mSin1. mTOR was first identified over two decades ago, and mTORC1 and mTORC2 have 
since been established as fundamental regulators of cell growth and metabolism1-3. The two 
mTOR complexes integrate some common activators such as growth factor-dependent 
phosphoinositide 3-kinase (PI3K) signalling to phosphorylate distinct downstream targets. The 
recruitment of these substrates is dictated by the differential scaffolding components of the 
complexes, i.e. Raptor vs Rictor2, 3. Broadly speaking, the major role of mTORC1 is to integrate 
the availability not only of growth factors, but also amino acids, oxygen and energy to promote 
biosynthesis of proteins, lipids and nucleotides. One of the key functions of mTORC1 is to 
drive protein translation via phosphorylation of proteins such as p70S6K and the ribosome-
associated 4EBP1 and by promoting ribosome biogenesis2, 3. The other major role for 
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mTORC1 is to inhibit the catabolic process of macroautophagy, hereafter referred to as 
autophagy, a cellular recycling process that can sequester contents of the cytoplasm either in 
bulk or selectively into specialised organelles called autophagosomes. Mature 
autophagosomes are trafficked along microtubules and ultimately fuse with lysosomes to form 
hybrid, degradative compartments called autolysosomes. The contents are then degraded and 
macromolecules such as amino acids and fatty acids can be liberated into the cytoplasm to 
support cellular growth and metabolism. Autophagy occurs in all cell types at basal levels that 
vary depending on cell function and metabolic demands but it is rapidly upregulated upon 
inhibition of mTORC14, 5. mTORC1 regulates autophagy via two major routes, firstly 
phosphorylation of ULK1/Atg1 kinase which is essential for autophagy induction and secondly 
by phosphorylating members of the TFEB family of transcription factors4-6. TFEB is a master 
regulator of autophagosome and lysosome gene transcription which is restrained in the 
cytoplasm by mTORC1 phosphorylation6. The second complex, mTORC2 on the other hand 
is implicated in controlling the cytoskeleton and membrane tension, proliferation and cell 
survival via substrates including Akt, PKC and SGK13, 7.  
In this review we will explore how mTOR, in particular mTORC1, is controlled by changes in 
the subcellular localisation of the complex itself and its regulators. The nutrient-dependent 
shuttling of mTORC1 between the cytoplasm and the late endosome/lysosome compartment, 
a discovery that fundamentally advanced our understanding of this signalling pathway has 
been the focus of several excellent reviews elsewhere1-3, 8, 9. Therefore, here we predominantly 
focus on other aspects of mTORC1 regulation by its spatial organisation within the cell. In 
particular, we will explore how increasing evidence places key mTORC1 regulators at multiple 
different sites in the cell including endoplasmic reticulum and plasma membrane. We will 
discuss how the endosomal and lysosomal pathways influence mTORC1 signalling and 
integrate these new insights to describe the emerging spatially dynamic model of mTORC1 
activation. 
2.1 mTORC1 at the lysosome 
In the presence of amino acids, mTORC1 localises to vesicular structures in mammalian cells 
that are positive for the late endosomal marker, Rab7 and lysosomal marker, Lamp110. This 
may indicate that mTORC1 localises to hybrid endolysosomal structures which contain active 
acid hydrolases to degrade cargo, as opposed to mature storage granule-like lysosomes 11. 
However, since localisation of the mTORC1 substrate, TFEB has been observed on both 
endolysosomes and lysosomes, it indicates the functional mTORC1 complex is likely present 
on both structures 11. TORC1 localisation to the vacuole membrane (equivalent of the 
lysosome) is conserved in yeast, indicating that this localisation is an important feature of 
3 
 
mTORC1 signalling, forcible removal of mTORC1 from this site inhibits its activity3, 9. mTORC1 
recruitment and retention on the lysosome is dependent on the atypical Rag family of Ras-
related small GTPases. There are four Rag proteins in mammals where RagA and RagB are 
functionally redundant and dimerise with either RagC or RagD, while in yeast the functional 
complex consists of Gtr1 and Gtr2 (homologues of RagA and RagC).  
Identifying the molecular mechanisms controlling the Rag-mTORC1 axis is a very active and 
dynamic area of research. Here we will describe the current model briefly as the focus of this 
review to explore the spatial control of mTORC1 more broadly. mTORC1 predominantly 
senses three amino acids, leucine, arginine and glutamine via a signalling cascade that leads 
to the GTP-loading of RagA/B and hydrolysis (of GTP to GDP) of RagC/D to form a 
heterodimer that can directly interact with mTORC19. Cytoplasmic sensors for leucine and 
arginine, Sestrin2 and CASTOR1/2 respectively, signal via a complex called GATOR2 to 
inhibit the RagA GTPase-activating protein (GAP) complex, GATOR1 so that in the presence 
of amino acids, RagA is in GTP-bound form, promoting a direct interaction with mTORC1, 
likely in the cytoplasm9, 12. The Rag-mTORC1 complex is then recruited to the lysosomal 
surface via the multi-protein RAGulator complex consisting of p18 (also known as LAMTOR1), 
p14 (LAMTOR2), MP1 (LAMTOR3), LAMTOR4 and LAMTOR5 8, 9.   
Several lysosomal transmembrane proteins co-operate with Rag-Ragulator axis to form a 
large, dynamic complex that tightly controls mTORC1 recruitment, retention and release from 
the lysosome. Specifically, the vacuolar ATPase (V-ATPase) proton pump which controls 
lysosomal pH, the amino acid transporter, SLC38A9 and the cholesterol transporter, NPC1 
have all been specifically implicated in transducing the availability of amino acids (particularly 
arginine) or cholesterol to mTORC1 from within the lysosomal lumen, in a Rag-dependent 
manner1, 8, 9. See Figure 1 for a diagram of the lysosome-localised mTORC1 machinery. The 
mechanistic details of how the availability of amino acids and other mitogens inside the 
lysosome versus in the cytoplasm is integrated by Ragulator-Rag are yet to be fully realised 
but for example conformational changes in V-ATPase and SLC38A9 in the presence of amino 
acids are required for mTORC1 activation 9, 13-15. 
A wide range of additional mechanisms have been implicated in relaying the availability of free 
amino acids, including glutamine (via  it’s metabolism to α-ketoglutarate16; and Arf1 activity 
17), asparagine (via Arf1)18 and leucine 19, phospholipase D20, 21 and energy 22 to mTORC1 via 
control of protein localisation to the lysosomal surface. These are reviewed elsewhere 3, 9, 23.  
Growth factor and energy availability is primarily transduced to mTORC1 via nucleotide 
loading of the small GTPase Rheb. Signalling downstream of PI3K/Akt, MEK/Erk and AMPK 
pathways leads to phosphorylation and inactivation of the Rheb-GAP, tuberous sclerosis 
4 
 
complex (TSC), which consists of three subunits, TSC1, TSC2 and TBC1D7. Amino acids, in 
particular arginine, cooperate with growth factors to ensure tight control of TSC localisation 
and thus activity24, 25 (Figure 1).  
The canonical model of mTORC1 activity works on the premise that mTORC1 is recruited to 
the lysosomal surface to facilitate its direct interaction with the small GTPase, Rheb in its GTP-
bound state, leading to a conformational change that activates mTORC1 by allowing access 
of substrates to the kinase domain. Indeed, there is ample evidence to support this hypothesis, 
including the observation that Rheb (both endogenous and overexpressed) is localised to the 
lysosome 10, 26-30 and that starvation-induced recruitment of TSC to the lysosome is Rheb-
dependent 24, 26. Rheb has however been equally noted to localise to a wide range of other 
endomembranes 27, 31, 32 33and we will discuss the repercussions of this for mTORC1 in section 
2.3. 
While overexpression of dominant-negative Rag GTPases, and forcible removal of mTORC1 
from the lysosome inhibits mTORC1, its global redistribution from the lysosome is not an 
absolute requirement to inactivate mTORC1. There are multiple reported cases whereby 
mTORC1 activity can still be inhibited but is retained on the lysosomal membrane, including 
in TSC2-null cells 25 and indeed there is still a significant proportion of mTOR-Lamp1 co-
localisation in starved HeLa cells (~30%, down from 50-60%) 24, 26.  This implies that 
conformational changes within the large lysosome-localised protein complex are sufficient to 
either preclude the mTORC1-Rheb interaction or mTORC1-substrate interactions. 
2.2 Why the lysosome?  
It is becoming increasingly clear that the lysosome is not simply a platform to support 
mTORC1-associated protein complexes but is rather an active participant in signalling and the 
lysosome plays a central role in coupling cellular anabolism and catabolism8, 23, 34. For 
example, loss of lysosomal membrane integrity inhibits mTORC1; damaged lysosomes leak 
luminal galactosides that are recognised by galectin8, the recruitment of which inhibits Rag-
dependent mTORC1 activity35. Furthermore, inhibition of lysosomal function, via targeting 
protease activity or the V-ATPase (which increases pH and reduces the activity of lysosomal 
hydrolases) can inactivate mTORC1 and activate autophagy 13, 36). Some of these effects can 
be attributed to a direct, although poorly understood role for the V-ATPase in controlling 
mTORC1 activity (see 9, 13). However, one reason why the lysosome is a prime site for 
mTORC1 residence is that lysosomal degradation generates free amino acids that can directly 
and indirectly activate mTORC1 (Figure 1). For example, mTORC1 reactivation after 
prolonged periods of starvation is dependent on liberation of amino acids via the autophagy-
lysosome pathway 37, 38. This reactivation of mTORC1 acts to reduce autophagy levels, limiting 
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degradation and promoting cell survival. Indeed, there is evidence that amino acid generation 
via the autophagy-lysosome pathway can be exploited to support ectopic activity of mTORC1 
in multiple models including cellular senescence39. Interestingly, while bulk autophagy would 
presumably replenish the entire intracellular pool of amino acids at ratios detected in the 
proteome, lysosome-dependent mechanisms have also been described that generate specific 
amino acids, glutamine 38 and arginine 40. The selective autophagic degradation of ribosomes 
can specifically help replenish arginine levels to activate mTORC1 while the generation of 
glutamine and its subsequent conversion to glutamate replenishes the pools of non-essential 
amino acids (NEAA) to activate mTORC1 during autophagy. Intriguingly, autophagy does not 
appear to contribute to the replenishment of essential amino acids (EAA) in myotubules 38, 41, 
potentially because EAA are very rapidly utilised. Indeed, starvation has widely been shown 
to cause a significant reduction in EAA whole cell extracts 38, 39, 42, however fascinatingly, their 
levels are maintained within lysosomes, via a mechanism that involves SLC38A942. By 
spatially segregating EAA into lysosomes, it may protect them from depletion via metabolism 
or protein translation during starvation 42. 
The spatial relationship between free amino acids and mTORC1 activation remains an 
evolving area of research. As discussed above, there are cytoplasmic sensors for the most 
potent of mTORC1 activators, leucine and arginine while there are complex mechanisms via 
which glutamine appears to be transduced to mTORC1 including via metabolism (to α-
ketoglutarate)16 and the Golgi-localised small GTPase, Arf1 17, 43. Most recently, sensing of 
asparagine was also found to occur via an Arf1-dependent mechanism18. These amino acids 
can be taken up from the environment by membrane transporters44, 45 or via macropinocytosis 
(as polypeptides)46, 47, they can be effluxed from the lysosome into the cytoplasm 48 and/or 
sensed from within the lysosome 13, 49. The ‘inside-out’ mechanisms of amino acid sensing 
involves free amino acids in the lysosomal lumen binding and causing a conformational 
change in V-ATPase13, while arginine-binding to SLC38A9 enhances its transport of polar 
amino acids to the cytoplasm where they can activate amino acid sensors 15, 49. 
Overexpression of the amino acid transporter, PAT1, has been shown to both activate 
mTORC1 (by replenishing the local, cytoplasmic concentrations of amino acids)48 and 
inactivate mTORC1 (by depleting the lysosome of amino acids) 13. The multiple routes via 
which amino acid availability (Figure 1) can be transduced to mTORC1 demonstrates the 
exquisite level of spatial and temporal control of mTORC1 signalling. The further development 
of techniques to measure individual amino acids and metabolites from isolated lysosomes and 
potentially other organelles such as mitochondria, will undoubtedly improve our resolution and 
understanding of the spatial relationship between amino acids, their metabolism and mTORC1 
activity. This will path the way to our understanding of whether different amino acids are 
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sensed preferentially in the cytoplasm versus lysosome, and whether different sites of sensing 
can illicit different downstream effects.   
2.3 Where is Rheb? 
The localisation of the activating small GTPase, Rheb remains one of the most elusive pieces 
of the mTORC1 signalling puzzle. Rheb binds directly to mTORC1, causing a conformational 
change that exposes the kinase domain to substrates50, 51. The consensus model of mTORC1 
signalling places Rheb on the lysosomal membrane 10, 26-30 creating a logical rationale that the 
Rag/Ragulator axis has evolved to support mTORC1 recruitment to this same membrane 
compartment and facilitate direct interaction between mTORC1-Rheb. However, while there 
are a significant number of reports of Rheb localising to lysosomes, numerous other reports 
place Rheb on ER membranes, Golgi membranes 27, 31, 32 and peroxisomes 33 (Figure 2).  
Recent insights into the biology of Rheb could bring together these previously conflicting data. 
Small GTPases contain a C-terminal CAAX box which is post-translationally modified with the 
addition of a farnesyl group to support recruitment of the proteins to endomembranes. 
Upstream of this is a hypervariable region with secondary targeting sequences. For example, 
in addition to farnesylation, Ras is also palmitoylated which promotes its localisation to the 
plasma membrane. Rheb however appears to lack any specific secondary targeting sequence 
in the hypervariable region and a recent report suggests that rather than being specifically 
anchored and enriched on lysosomes, Rheb can target endomembranes indiscriminately and 
that transient localisation of Rheb to lysosomes is sufficient to activate mTORC132. Since 
many reports place Rheb on ER and Golgi membranes, one hypothesis has been these Rheb-
positive membranes interact with mTORC1-positive lysosomes and these contact sites 
facilitate mTORC1 activation 31. Constitutive targeting of Rheb to the ER membrane however 
fails to activate mTORC1 despite the fact that lysosome-ER contacts are still observed, 
indicating that Rheb does not activate mTORC1 by bridging across the two membranes32. 
Rather, the authors suggest that the ER localisation often identified for Rheb is simply a default 
localisation of farnesylated proteins32. 
Without a specific targeting sequence, how exactly is the dynamic flux of Rheb between 
membranes and the cytoplasm controlled? Recently, a mechanism of spatial cycling of Rheb 
was described which acts to deliver and enrich Rheb specifically on lysosomes, despite the 
absence of a dedicated targeting sequence 30. The model proposes that the interaction 
between Rheb and a GDI-like solubilising factor (GSF), PDEδ 52 maintains Rheb-GDP in the 
cytoplasm. Soluble Rheb has previously been shown to have increased nucleotide exchange 
compared to membrane-bound Rheb 53, 54 and thus the authors suggest that PDEδ supports 
Rheb nucleotide exchange (GTP loading) in the cytoplasm. If this is correct, it could negate a 
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need for, or argue against the existence of a Rheb-GEF, a long postulated but elusive 
regulator of mTORC1 signalling to maintain the very high levels of Rheb-GTP observed in the 
cell 55. Rheb-GTP is released from PDEδ upon PDEδ-Arl2-GTP binding, an interaction that 
occurs predominately in the perinuclear region (Figure 1). The authors suggest this interaction 
locally enriches Rheb-GTP in proximity to lysosomes thus favouring its recruitment to this 
site30. There are conflicting views indicating that the interaction between Rheb and mTORC1 
then supports retention of Rheb on lysosomes 30 while another report suggests that Rheb-
GTP cooperates with Rag GTPases to recruit or retain mTORC1 on lysosomal surfaces25. 
Specifically, overexpression of active Rheb was found to be sufficient to recruit mTORC1 to 
the lysosomal membrane even in the absence of amino acids and indeed in TSC2-/- MEFs, 
where Rheb is constitutively active, mTORC1 fails to redistribute to the cytoplasm upon 
starvation 25. 
2.4 Rheb-TSC interaction 
The spatial cycling model for Rheb regulation is completed by TSC-dependent hydrolysis of 
Rheb, promoting its re-solubilisation via PDEδ30. Inhibition of TSC by genetic KO or insulin, 
leads to increased Rheb-GTP on membranes30 while activation of TSC during starvation, 
leads to its recruitment to lysosomal membranes via a poorly understood mechanism that has 
been postulated to be Rheb-dependent and Rag GTPase-dependent 24-26. Our own data 
indicate that overexpression of wild-type or active Rheb is sufficient to recruit TSC to the 
lysosome 24. We have hypothesised that TSC recruitment to the lysosome is able to physically 
limit the interaction between mTORC1 and Rheb; TSC can prevent constitutively active Rheb-
dependent mTORC1 signalling while over-expression of TSC2 GAP-dead mutants are also 
still able to inhibit mTORC1 activity. There is still a lot to understand regarding the complex 
spatial relationship between TSC-Rheb-mTOR at the lysosome; for example, does Rheb 
recruit mTORC1? Does mTORC1 help retain Rheb on lysosomes? and how or why is TSC 
stably recruited to the lysosomal membranes in starvation, especially if starvation leads to a 
reduction in Rheb from the lysosomal membrane? And does the TSC complex indeed have 
additional roles in controlling the Rheb-mTORC1 axis than simply acting as a Rheb-GAP? 
Furthermore, TSC and Rheb have also been observed to localise to peroxisomes to control 
mTORC1 in response to oxidative stress33, so could different stress/nutrient mechanisms 
control the site-specific localisation of TSC or Rheb? 
2.2 Lysosomal localisation 
As we have discussed, lysosomal function and membrane integrity are essential for proper 
control of mTORC1. Often however we depict lysosomes as discrete, terminal degradative 
units while in reality they are extremely dynamic organelles that are capable of moving at 0.2-
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0.6µm/s-1 56, 57, and are in constant flux with trafficking pathways delivering intracellular and 
extracellular cargo for degradation via the autophagy and endocytic/macropinocytic pathways, 
respectively. Importantly, the subcellular distribution of lysosomes is dictated by mitogenic 
signals and correlates with mTORC1 activity34, 58-60. In particular, addition of the growth factor-
rich supplement foetal calf serum (FCS) to culture media and the resulting reduction in 
intracellular pH leads to kinesin-dependent dispersal of lysosomes along microtubules, to the 
cell periphery 58, 61-63. Nutrient starvation on the other hand promotes the dynein-dependent 
clustering of lysosomes in the juxta-nuclear region, a localisation that  supports starvation-
induced autophagy via mTORC1 inhibition 58, and by facilitating increased activity of 
lysosomes (i.e., lower pH and increased access to Golgi-derived newly synthesised lysosomal 
hydrolases compared to lysosomes at the periphery) 64 (Figure 1 and 2). 
Peripheral localisation of mTORC1-positive lysosomes directly contributes to mTORC1 
activity and is proposed to be facilitated by proximity to mitogenic inputs i.e. growth factor 
receptors, amino acid receptors, macropinosomes. Indeed an enrichment of phosphorylated 
Akt at the plasma membrane is observed following serum addition 58, 59  and ~70% of free 
cytoplasmic leucine is taken up via plasma membrane transporters such as LAT1 (SLC7A5)45. 
Forced peripheral spreading of lysosomes by overexpression of the small GTPase ARL8B, 
which couples lysosomes to kinesins, is sufficient to increase mTORC1 activity, albeit 
marginally, but this forced re-localisation is neither sufficient for mTORC1 activation in 
starvation nor is it absolutely necessary 58, 60. For example, lysosomal clustering by ARL8B 
loss, knock-out of kinesin proteins, KIF1B-KIF5B or the BORC component, myrlysin (BORC 
is a lysosome-localised multi-subunit complex that facilitates ARL8B recruitment) delays but 
does not inhibit the reactivation of mTORC1 following starvation and the effect may be specific 
to serum but not amino acids 58, 60. In another study however, amino acids have been 
implicated in lysosome spreading and thus mTORC1 activation. In this model, amino acid 
replenishment activates the Vps34-dependent production of PI3P on lysosomes, promoting 
the PI3P and Rab7-dependent interaction of lysosomes with the ER-resident protein 
protrudin1 which facilities the transfer of kinesins to the PI3P-binding protein FYCO1 59, 65. 
Amino acid starvation on the other hand promotes recruitment of the RagC GAP, Folliculin to 
the lysosome which supports clustering of lysosomes by tethering them to the Golgi via 
Rab34-RILP complex66. Therefore, while the role of amino acids in controlling mTORC1 
activity is clear, their role in controlling lysosome spreading remains to be clarified.  
Common regulators couple lysosome localisation and mTORC1 activation, adding further 
layers of co-regulation between the two. Specifically, the Ragulator component p18/LAMTOR1 
interacts with the BORC complex 67, an association that is reduced in the presence of EGF 68. 
Reduced BORC-p18 binding leads to increased BORC-dependent recruitment of ARL8B to 
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late endosomes/lysosomes to promote their dispersal to the periphery. Thus, p18 plays a dual 
role, regulating the recruitment of mTORC1 to the lysosome and the movement of mTORC1-
positive lysosomes to a region enriched in mitogens.  
In addition to mTORC1, at least a portion of mTORC2 also reside on endosomes 69 and 
lysosomes and their localisation also controls growth factor activation of mTORC2 substrates 
60. Further pools of mTORC2 have been noted at the plasma membrane, mediated by PH-
domain containing subunit mSin1 and the adaptor, syndecan 4 69-71. Further work to explore 
the spatial and temporal control of mTORC1 versus mTORC2 on lysosomal membranes, how 
mTORC2 is recruited to lysosomal membranes and what, if any the specific role for this pool 
of mTORC2 will expand our knowledge of lysosome-controlled cellular metabolism. 
The peripheral localisation of lysosomes thus spatially integrates nutrient input with mTORC1 
activation and in the next section we will be explore how together they may co-operate to a 
previously unrecognised degree at the cell surface to control cell size, growth and migration.  
2.5 mTORC1 and the plasma membrane 
 
Although the increased activation of mTORC1 in cells with peripheral lysosomes has been 
postulated to be as a result of  proximity to mitogenic inputs, it’s not clear whether this occurs 
in any specific region of the plasma membrane, is facilitated by direct interactions or via signal 
transduction and whether there is any site-specific role for mTORC1 activity at the cell 
periphery (Figure 1).  
Peripheral lysosomes contribute to the turnover of focal adhesions, integrin-based complexes 
that anchor cells to the extracellular matrix. Specifically, the Ragulator components, p14-
MP1/LAMTOR2-3 are required to remove IQGAP from focal adhesions to promote cell 
migration 72. The mTORC1-inhibitor, rapamycin also inhibits cell migration via a mechanism 
involving S6K and 4E-BP173, raising the possibility that mTORC1 on lysosomes in the 
periphery may co-operate to facilitate a site-specific role in the turnover, maintenance or 
stability of adhesion complexes either via tight, localised regulation of protein translation or 
autophagy-lysosome dependent degradation. This concept would be particularly interesting to 
explore in cancer cells that are frequently characterised by increased mTORC1 activity and 
often display a peripheral distribution of lysosomes 74, 75. At the same time a recent report 
demonstrated that increased stiffness of the extracellular matrix can increase mTORC1 
activity via cooperation with integrins in breast cancer76. Alternatively, lysosomal pools of 
mTORC2 69 could regulate the cytoskeleton 77 at the periphery to control cell migration. Further 
studies are required to determine if there is a functional link required for cancer cell growth, 
migration, metastases or survival.  
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Furthermore, although there is currently no known role identified for mTORC1, BORC-
dependent re-localisation of lysosomes to the cell periphery and their subsequent exocytosis 
provides membrane to support plasma membrane repair and increased cell size 67, 78-80. So, 
while there are several reported roles for lysosomes in the cell periphery, there has been little 
focus on whether mTORC1, localised to these organelles may functionally cooperate to control 
cell migration or cell size. There is however evidence that surface membrane potential and 
plasma membrane tension can influence mTORC1 (and mTORC2). Indeed, hyperpolarisation 
of the membrane can restore ectopic mTORC1 activity in a model of senescence39 while 
decreased tension leads to a rearrangement of PIP2 and inactivation of mTORC281. 
mTORC1 beyond the lysosome 
It is an attractive, logical model whereby amino acids promote the recruitment of mTORC1 to 
Rheb-enriched lysosomes, and subsequently re-localise these mTORC1-positive lysosomes 
to the cell periphery where Rheb-GTP loading is enhanced by activated growth factor receptor/ 
PI3K/Akt signalling. In the next sections, we will explore how this model spatially integrates 
with our expanding understanding of how the endosomal, autophagosomal and secretory 
pathways transduce nutrient availability and control mTORC1 localisation and activity. 
2.6 mTORC1 and the endosomal pathway 
The endosomal pathway controls the internalisation and turnover of surface proteins such as 
receptors, adhesion molecules and transporters which are taken up into Rab5-decorated early 
endosomes and then either trafficked back to the cell surface or targeted for degradation via 
late endosomes and lysosomes82. Several studies indicate the endosomal pathway can impact 
mTORC1 activity (and vice versa) via a number of both direct and indirect mechanisms, 
including via delivery of nutrient receptors to the cell surface83, controlling protein topography 
on the lysosomal membrane 84and delivery of RagD- and SLC38A9-positive endosomes to 
endolysosome compartments85 (Figure 1).  
The endosomal pathway has been implicated in regulating both growth factor-dependent and 
Rag-dependent activation of mTORC1 43, 45, 83-85. For example, genetic inhibition of dynamin-
dependent endocytosis 45 and depletion of components of the major endosomal recycling 
complex, retromer 83, 84, reduces mTORC1 activity.  Retromer loss leads to gross changes in 
the localisation of proteins on the surface of the lysosome. TBC1D5, a Rab7 GAP and 
retromer-interacting protein can restrict the localisation of Rab7a to discrete regions on the 
lysosomal membrane.  The loss of TBC1D5 leads to a redistribution of Rab7a and significant 
increase in Rab7 co-localisation with LAMTOR, proteins which are usually spatially 
segregated84. The authors propose this leads to reduced Rag GTPase and mTORC1 
localisation to the lysosome, changes in lysosomal distribution, and decreased mTORC1 
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activity. At the same time, retromer is also required for the adaptive delivery of glutamine 
transporters such as SNAT1 (SLC38A1) and LAT1 (SLC7A5) to the cell surface during 
starvation to facilitate nutrient uptake83 (Figure 1). Several endosomal regulators 85 and 
retromer subunits have been identified as transcriptional targets of TFEB and are thus 
upregulated upon starvation to promote the roles described above (Figure 2).  
Proper maturation through the endosomal pathway controls nutrient-dependent mTORC1 
activity. TFEB-regulated endocytosis supports the generation of so-called ‘signalling 
endosomes’ that are required to deliver mTORC1-associated machinery to late endosomes 
and activate Akt 85. At the same time, while Rab5-dependent PI3P production, downstream of 
amino acids normally promotes the activation of mTORC1 86, overexpression of constitutively 
active Rab5 (Rab5Q79L) leads to the formation of distinctive, enlarged hybrid structures as a 
result of impaired transition of early-to-late endosomes, and inhibits mTORC1 in response to 
both amino acids and growth factors87. Interestingly, only overexpression of Rheb, not 
activation of endogenous Rheb (i.e. TSC2 knock-out) can activate mTORC1 in these cells. 
Coupled with the fact that the mTORC1 complex localises to the Rab5-positive hybrid 
endosomes, together, these data support a model whereby mTORC1 is spatially segregated 
from Rheb in Rab5 over-expressing cells, supporting the hypothesis that Rheb is localised to 
the mature late endosome and/or lysosome. These data are interesting considering the new 
studies discussed in section 2.3, given that Rheb could presumably still transiently interact 
with the membrane of these Rab5-positive, mTOR-positive structures. It is possible that in 
cells with defective endosomal maturation, the large, dynamic mTORC1-regulating complex 
is not properly assembled.   
The spatial control of lipids is essential for the proper regulation of endosomal and other 
membrane trafficking pathways and can impact mTORC1 via multiple mechanisms. The class 
III PI3K, hVps34 represents an interesting spatial regulator of the mTORC1-autophagy 
pathway by forming multiple complexes that act both upstream and downstream of mTORC1 
to control the activation of both mTORC1 and autophagy. Vps34 is a well-known regulator of 
autophagy, and forms a complex with Beclin1, Atg14 and Vps15 to promote PI3P required for 
autophagosome formation, and indeed mTORC1 phosphorylation of Atg14 in this complex 
inhibits the induction of autophagy  88. Furthermore, mTORC1 phosphorylation of UVRAG in 
another Vps34-containing complex controls PI3P-dependent tubulation of autolysosomal 
membranes to support the resolution endo/autolysosomes 89. At the same however, Vps34 -
dependent production of PI3P in response to amino acids and glucose has also been shown 
to act upstream of mTORC1 and be a positive regulator of its activity. Production of another 
lipid, PI(3,4)P2,  produced in the vicinity of RPTR at the lysosome by class II PI3K b (PI3K C2b) 
represses mTORC1 by promoting association between 14-3-3 and RPTR. Thus, lipid kinases 
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in complex with different regulators participate in the tight spatial control of lipid synthesis to 
control the balance between mTORC1 and autophagy activity.  
Our understanding of the complex, direct and indirect ways in which the endosomal pathway 
influences nutrient-dependent mTORC1 is growing rapidly. The simplistic view that 
endocytosis and recycling control mTORC1 through localisation of surface receptors has 
expanded to include the specific delivery of regulatory proteins, complexes and lipids to ensure 
tight spatial and temporal control of mTORC1 signalling. At the same time, we are only just 
beginning to understand how different nutrient uptake routes i.e. transporters vs endocytosis 
vs macropinocytosis integrate and cooperate with lysosome-derived amino acids and growth 
factor signalling to control the balance between cellular anabolism, catabolism and survival. 
Indeed, macropinocytotic uptake and utilisation of extracellular protein as a nutrient source to 
activate mTORC1 only occurs in amino acid-depleted conditions. In these low amino acid, 
high protein culturing conditions, active mTORC1 actually inhibits proliferation, which together 
indicates mTORC1 can not only sense the quality and source of nutrients but that that cells 
significantly favour the uptake and use of free amino acids 46, 47. At the moment it is not clear 
where or how this sensing occurs, and future work will expand our knowledge of how nutrients 
are taken up, sensed and utilised via the mTORC1 pathway.  
2.7 Spatial association of mTORC1 and autophagy  
As mentioned previously, there is tight spatial cycling between the activity of mTORC1 and 
autophagy that is essential to control cell growth and survival via balancing anabolic versus 
catabolic metabolism4. In particular, the ER is a central regulator of the tight spatial association 
between lysosome function, mTORC1 activity and autophagy. The close association of 
mTORC1-positive lysosomes with ER also spatially coordinates with autophagy initiation 
which is negatively controlled by mTORC1-dependent phosphorylation of ULK1, the 
autophagy initiating protein4, 5. Inhibition of mTORC1 leads to the recruitment of ULK1 complex 
to the ER membrane, which together with Vps34-containing class III PI3K complex and Atg9-
decorated vesicles derived from the Golgi participates in the formation of the PI3P-enriched 
omegasome. By sequestering membrane from various intracellular sites including ER, plasma 
membrane and Golgi 5, 90, sites also implicated in controlling mTORC1 activity 91, the 
omegasome develops into immature phagophore and from there, a mature autophagosome. 
En-route to the lysosome, autophagosomes can interact with the endosomal pathway to form 
hybrid structures called amphisomes. Ultimately, cargo from starvation-induced 
autophagosomes and amphisomes is delivered to and degraded by lysosomes and can then 
directly reactivate mTORC1 (Figure 2).  
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Another key regulator of the complex interplay between mTORC1 and autophagy are 
members of the TFEB-family of transcription factors. Starvation-induced translocation of TFEB 
to the nucleus can ultimately impact mTORC1 activity both directly and indirectly by controlling 
the expression of RagD and autophagy/lysosomes genes, respectively 6, 92.  
mTORC1 and the secretory pathway  
In the next section we will discuss the increasingly evident role for the ER and Golgi in 
controlling mTORC1, from signalling, to membrane tethering and membrane-membrane 
contact sites.  
2.8 mTORC1 and Golgi 
Several studies have observed mTORC1 localising to the Golgi membrane independently and 
in addition to the pool of mTORC1 on lysosomes 93-95. At the same time, the Golgi-associated 
small GTPases Arf1 and Rab1 can activate mTORC1 via poorly understood mechanisms 43 
(Figure 2). Arf1 specifically transduces glutamine availability to mTORC1 via a mechanism 
that promotes mTORC1 to the lysosomal membrane independently of Rag-Ragulator but still 
dependent on V-ATPase17. Further studies implicate the Golgi-resident amino acid 
transporter, PAT4 in recruiting mTORC1 to Golgi membranes which is important to sense the 
availability of glutamine and serine in fast growing colorectal cancer cells94. Similarly, GTP 
loading of Rab1 by amino acids can activate mTORC1 and in cancers such as colon cancer, 
Rab1 overexpression and increased mTORC1 drive tumorigenesis 96. There is certainly an 
emerging picture whereby the Golgi is important for sensing glutamine availability to mTORC1 
and it remains to be seen to which extent this is mediated by signal transduction or direct 
interactions. As a conditionally essential amino acid, glutamine is particularly important in fast-
growing cells such as cancer cells and thus cells with different metabolic demands may utilise 
different or additional pools of mTORC1 to sustain increased growth and proliferation.  
2.9 mTORC1 and ER 
The endoplasmic reticulum (ER) is a site that coordinates the folding and transport of new 
proteins, as well as sorting and recycling of proteins via the endosomal pathway. There are 
no reports that mTORC1 localises to the ER but there are both direct and indirect mechanisms 
via which ER can influence mTORC1 activity. In particular, that the master activator of 
mTORC1, Rheb has been widely observed on ER membranes and previous reports have 
suggested that contact sites between lysosome-bound mTORC1 and ER membranes facilitate 
mTORC1-Rheb interactions (as discussed above).  
A number of ER-resident proteins can indirectly influence mTORC1 activity by controlling the 
localisation of lysosomes, including protrudin- (via Rab7-FYCO1-kinesins)59, 65 and VAPA- (via 
the lysosomal cholesterol sensor, ORP1L and Rab7) in response to nutrient availability. 
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Further to this, recent evidence indicates that lysosome-ER contact sites that facilitate the flux 
of cholesterol can directly influence mTORC1. Indeed, apart from amino acids, cholesterol is 
only other metabolite currently known to activate mTORC1 from within the lysosome, and it 
does so via a Rag-dependent mechanism involving the cholesterol transporter NPC1 and 
SCL38A9 but independent of amino acid availability 97 (Figure 2). Mutations in NPC1 cause 
the neurodegenerative, lysosomal storage disease Niemann-Pick disease type C1 which is 
characterised by the accumulation of lysosomal cholesterol, impaired autophagy and ectopic 
activation of mTORC197-99. A recent study demonstrated that these phenotypes are caused by 
the VAPA-ORP1L-dependent, ER-to-lysosome transfer of cholesterol which fails to be 
effluxed efficiently by mutant NPC1. Inhibiting cholesterol transfer to the lysosome can restore 
mTORC1 and autophagy in NPC1-null cells 99 while activation of autophagy can also help in 
clearing cholesterol-filled lysosomes 98 and as discussed above, the ER represents an 
important co-ordinator for the mTORC1-autophagy pathway. 
2.10 mTORC1 in the nucleus 
Numerous studies have identified mTOR in the nucleus, both as a part of mTORC1 and 
mTORC2 100. Inhibition of nuclear export by leptomycin B leads to an accumulation of mTOR 
and Raptor in the nucleus 101, 102, and inhibition of pS6K and p4EBP1 102 suggesting that 
nucleo-cytoplasmic shuttling of mTORC1 occurs. Most reports however agree that mTORC1-
dependent phosphorylation of downstream targets occurs primarily in the cytoplasm 103, 104. 
There are however reports that pools of mTORC1 in the nucleus may contribute to 
transcriptional regulation in health 105 and disease 106. Furthermore, independent work from 
two labs indicates that phosphorylation of TFEB by mTORC1 is required for its exit from the 
nucleus 107, 108 and although it has not yet been formally addressed, could it be possible that 
nuclear mTORC1 phosphorylates TFEB? 
2.11 mTORC1 in the cytoplasm  
A third, cytoplasmic mTOR complex 3 was recently described whereby mTOR associates with 
the transcription factor ETV7, independently of its function as a transcription factor, and forms 
a rapamycin-insensitive complex. ETV7 is highly upregulated in a wide range of cancers, 
including 85% of medulloblastoma’s and the authors propose that rapamycin insensitivity 
observed in many cancers is a result of increased mTORC3 109.  
3. Conclusion 
Complex mechanisms have evolved to maintain optimal levels of cell growth in response to 
constantly changing nutrient availability. At the heart of this lies the mTORC1 signalling 
network which, as we have discussed is controlled by tight, nutrient-responsive changes in 
subcellular localisation of multiple regulators. The nutrient-dependent cytoplasm-lysosome 
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shuttling of mTORC1 components coupled with the dynamic movement and interaction of 
mTORC1-decorated lysosomes between distinct regions of the cell including plasma 
membrane, ER and Golgi allow for exquisite control of mTORC1 activation. Moving ahead, 
the field will undoubtedly reveal new insights into the spatial control of mTORC1; just a few of 
the important questions remaining include how and where the Rheb-mTORC1 interaction is 
controlled, to what extent do different sources of nutrients (i.e. autophagy vs macropinocytosis 
vs nutrient transporters) effect mTORC1 activity, how are amino acid signals transduced from 
the Golgi to the lysosome and a better mechanistic understanding of how maturation through 
the endosomal pathway controls mTORC1.   
4. Acknowledgements  
B.C is supported by British Skin Foundation Young Investigator Award and University of Bristol 
Vice-Chancellor’s Fellowship. 
5. References 
1. Sabatini, D.M. Twenty-five years of mTOR: Uncovering the link from nutrients to growth. 
Proc Natl Acad Sci U S A 114, 11818-11825 (2017). 
2. Saxton, R.A. & Sabatini, D.M. mTOR Signaling in Growth, Metabolism, and Disease. Cell 168, 
960-976 (2017). 
3. Shimobayashi, M. & Hall, M.N. Making new contacts: the mTOR network in metabolism and 
signalling crosstalk. Nat Rev Mol Cell Biol 15, 155-162 (2014). 
4. Carroll, B., Korolchuk, V.I. & Sarkar, S. Amino acids and autophagy: cross-talk and co-
operation to control cellular homeostasis. Amino acids 47, 2065-2088 (2015). 
5. Yu, L., Chen, Y. & Tooze, S.A. Autophagy pathway: Cellular and molecular mechanisms. 
Autophagy 14, 207-215 (2018). 
6. Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 1429-1433 
(2011). 
7. Gaubitz, C., Prouteau, M., Kusmider, B. & Loewith, R. TORC2 Structure and Function. Trends 
Biochem Sci 41, 532-545 (2016). 
8. Lawrence, R.E. & Zoncu, R. The lysosome as a cellular centre for signalling, metabolism and 
quality control. Nat Cell Biol 21, 133-142 (2019). 
9. Wolfson, R.L. & Sabatini, D.M. The Dawn of the Age of Amino Acid Sensors for the mTORC1 
Pathway. Cell Metab 26, 301-309 (2017). 
10. Sancak, Y. et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is 
necessary for its activation by amino acids. Cell 141, 290-303 (2010). 
11. Bright, N.A., Davis, L.J. & Luzio, J.P. Endolysosomes Are the Principal Intracellular Sites of 
Acid Hydrolase Activity. Curr Biol 26, 2233-2245 (2016). 
12. Lawrence, R.E. et al. A nutrient-induced affinity switch controls mTORC1 activation by its Rag 
GTPase-Ragulator lysosomal scaffold. Nat Cell Biol 20, 1052-1063 (2018). 
13. Zoncu, R. et al. mTORC1 senses lysosomal amino acids through an inside-out mechanism 
that requires the vacuolar H(+)-ATPase. Science 334, 678-683 (2011). 
14. Wang, S. et al. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine 
sufficiency to mTORC1. Science 347, 188-194 (2015). 
15. Rebsamen, M. et al. SLC38A9 is a component of the lysosomal amino acid sensing machinery 
that controls mTORC1. Nature 519, 477-481 (2015). 
16 
 
16. Duran, R.V. et al. Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 47, 349-358 
(2012). 
17. Jewell, J.L. et al. Metabolism. Differential regulation of mTORC1 by leucine and glutamine. 
Science 347, 194-198 (2015). 
18. Meng, D. et al. Glutamine and asparagine activate mTORC1 independently of Rag GTPases. J 
Biol Chem (2020). 
19. Han, J.M. et al. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-
signaling pathway. Cell 149, 410-424 (2012). 
20. Sun, Y. et al. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad 
Sci U S A 105, 8286-8291 (2008). 
21. Bernfeld, E. et al. Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by 
glutamine. J Biol Chem 293, 16390-16401 (2018). 
22. Zhang, C.S. et al. The lysosomal v-ATPase-Ragulator complex is a common activator for 
AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab 20, 
526-540 (2014). 
23. Carroll, B. & Dunlop, E.A. The lysosome: a crucial hub for AMPK and mTORC1 signalling. 
Biochem J 474, 1453-1466 (2017). 
24. Carroll, B. et al. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. 
eLife 5 (2016). 
25. Demetriades, C., Doumpas, N. & Teleman, A.A. Regulation of TORC1 in response to amino 
acid starvation via lysosomal recruitment of TSC2. Cell 156, 786-799 (2014). 
26. Menon, S. et al. Spatial control of the TSC complex integrates insulin and nutrient regulation 
of mTORC1 at the lysosome. Cell 156, 771-785 (2014). 
27. Buerger, C., DeVries, B. & Stambolic, V. Localization of Rheb to the endomembrane is critical 
for its signaling function. Biochem Biophys Res Commun 344, 869-880 (2006). 
28. Clark, G.J. et al. The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling 
and transformation. J Biol Chem 272, 10608-10615 (1997). 
29. Fawal, M.A., Brandt, M. & Djouder, N. MCRS1 binds and couples Rheb to amino acid-
dependent mTORC1 activation. Dev Cell 33, 67-81 (2015). 
30. Kovacevic, M.K., C.H; Roßmannek, L; Konitsiotis AD; Stanoev, A; Kraemer, AU; Bastiaens, PIH 
A spatially regulated GTPase cycle of Rheb controls growth factor signaling to mTORC1. 
bioRxiv (2018). 
31. Hao, F. et al. Rheb localized on the Golgi membrane activates lysosome-localized mTORC1 at 
the Golgi-lysosome contact site. J Cell Sci 131 (2018). 
32. Angarola, B. & Ferguson, S.M. Weak membrane interactions allow Rheb to activate mTORC1 
signaling without major lysosome enrichment. Mol Biol Cell 30, 2750-2760 (2019). 
33. Zhang, J. et al. A tuberous sclerosis complex signalling node at the peroxisome regulates 
mTORC1 and autophagy in response to ROS. Nat Cell Biol 15, 1186-1196 (2013). 
34. Ballabio, A. & Bonifacino, J.S. Lysosomes as dynamic regulators of cell and organismal 
homeostasis. Nat Rev Mol Cell Biol (2019). 
35. Jia, J. et al. Galectins Control mTOR in Response to Endomembrane Damage. Mol Cell 70, 
120-135 e128 (2018). 
36. Li, M. et al. Suppression of lysosome function induces autophagy via a feedback down-
regulation of MTOR complex 1 (MTORC1) activity. J Biol Chem 288, 35769-35780 (2013). 
37. Yu, L. et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. 
Nature 465, 942-946 (2010). 
38. Tan, H.W.S., Sim, A.Y.L. & Long, Y.C. Glutamine metabolism regulates autophagy-dependent 
mTORC1 reactivation during amino acid starvation. Nat Commun 8, 338 (2017). 
39. Carroll, B. et al. Persistent mTORC1 signaling in cell senescence results from defects in amino 
acid and growth factor sensing. J Cell Biol 216, 1949-1957 (2017). 
17 
 
40. Wyant, G.A. et al. NUFIP1 is a ribosome receptor for starvation-induced ribophagy. Science 
360, 751-758 (2018). 
41. Yu, X. & Long, Y.C. Autophagy modulates amino acid signaling network in myotubes: 
differential effects on mTORC1 pathway and the integrated stress response. FASEB J 29, 394-
407 (2015). 
42. Abu-Remaileh, M. et al. Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent 
regulation of amino acid efflux from lysosomes. Science 358, 807-813 (2017). 
43. Li, L. et al. Regulation of mTORC1 by the Rab and Arf GTPases. J Biol Chem 285, 19705-19709 
(2010). 
44. Nicklin, P. et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 
136, 521-534 (2009). 
45. Persaud, A., Cormerais, Y., Pouyssegur, J. & Rotin, D. Dynamin inhibitors block activation of 
mTORC1 by amino acids independently of dynamin. J Cell Sci 131 (2018). 
46. Palm, W., Araki, J., King, B., DeMatteo, R.G. & Thompson, C.B. Critical role for PI3-kinase in 
regulating the use of proteins as an amino acid source. Proc Natl Acad Sci U S A 114, E8628-
E8636 (2017). 
47. Palm, W. et al. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by 
mTORC1. Cell 162, 259-270 (2015). 
48. Ogmundsdottir, M.H. et al. Proton-assisted amino acid transporter PAT1 complexes with Rag 
GTPases and activates TORC1 on late endosomal and lysosomal membranes. PLoS One 7, 
e36616 (2012). 
49. Wyant, G.A. et al. mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids 
from Lysosomes and Use Protein as a Nutrient. Cell 171, 642-654 e612 (2017). 
50. Yang, H. et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 
552, 368-373 (2017). 
51. Chao, L.H. & Avruch, J. Cryo-EM insight into the structure of MTOR complex 1 and its 
interactions with Rheb and substrates. F1000Res 8 (2019). 
52. Ismail, S.A. et al. Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated 
cargo. Nat Chem Biol 7, 942-949 (2011). 
53. Li, Y., Inoki, K. & Guan, K.L. Biochemical and functional characterizations of small GTPase 
Rheb and TSC2 GAP activity. Mol Cell Biol 24, 7965-7975 (2004). 
54. Mazhab-Jafari, M.T. et al. Membrane-dependent modulation of the mTOR activator Rheb: 
NMR observations of a GTPase tethered to a lipid-bilayer nanodisc. J Am Chem Soc 135, 
3367-3370 (2013). 
55. Inoki, K., Li, Y., Xu, T. & Guan, K.L. Rheb GTPase is a direct target of TSC2 GAP activity and 
regulates mTOR signaling. Genes Dev 17, 1829-1834 (2003). 
56. Balint, S., Verdeny Vilanova, I., Sandoval Alvarez, A. & Lakadamyali, M. Correlative live-cell 
and superresolution microscopy reveals cargo transport dynamics at microtubule 
intersections. Proc Natl Acad Sci U S A 110, 3375-3380 (2013). 
57. Bandyopadhyay, D., Cyphersmith, A., Zapata, J.A., Kim, Y.J. & Payne, C.K. Lysosome transport 
as a function of lysosome diameter. PLoS One 9, e86847 (2014). 
58. Korolchuk, V.I. et al. Lysosomal positioning coordinates cellular nutrient responses. Nat Cell 
Biol 13, 453-460 (2011). 
59. Hong, Z. et al. PtdIns3P controls mTORC1 signaling through lysosomal positioning. The 
Journal of cell biology 216, 4217-4233 (2017). 
60. Jia, R. & Bonifacino, J.S. Lysosome Positioning Influences mTORC2 and AKT Signaling. Mol 
Cell 75, 26-38 e23 (2019). 
61. Parton, R.G. et al. pH-induced microtubule-dependent redistribution of late endosomes in 
neuronal and epithelial cells. J Cell Biol 113, 261-274 (1991). 
62. Heuser, J. Changes in lysosome shape and distribution correlated with changes in 
cytoplasmic pH. J Cell Biol 108, 855-864 (1989). 
18 
 
63. Moolenaar, W.H. Effects of growth factors on intracellular pH regulation. Annu Rev Physiol 
48, 363-376 (1986). 
64. Johnson, D.E., Ostrowski, P., Jaumouille, V. & Grinstein, S. The position of lysosomes within 
the cell determines their luminal pH. J Cell Biol 212, 677-692 (2016). 
65. Raiborg, C. et al. Repeated ER-endosome contacts promote endosome translocation and 
neurite outgrowth. Nature 520, 234-238 (2015). 
66. Starling, G.P. et al. Folliculin directs the formation of a Rab34-RILP complex to control the 
nutrient-dependent dynamic distribution of lysosomes. EMBO Rep 17, 823-841 (2016). 
67. Pu, J., Keren-Kaplan, T. & Bonifacino, J.S. A Ragulator-BORC interaction controls lysosome 
positioning in response to amino acid availability. J Cell Biol 216, 4183-4197 (2017). 
68. Filipek, P.A. et al. LAMTOR/Ragulator is a negative regulator of Arl8b- and BORC-dependent 
late endosomal positioning. J Cell Biol 216, 4199-4215 (2017). 
69. Ebner, M., Sinkovics, B., Szczygiel, M., Ribeiro, D.W. & Yudushkin, I. Localization of mTORC2 
activity inside cells. J Cell Biol 216, 343-353 (2017). 
70. Betz, C. et al. Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated 
endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl 
Acad Sci U S A 110, 12526-12534 (2013). 
71. Partovian, C., Ju, R., Zhuang, Z.W., Martin, K.A. & Simons, M. Syndecan-4 regulates 
subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent 
manner in endothelial cells. Mol Cell 32, 140-149 (2008). 
72. Schiefermeier, N. et al. The late endosomal p14-MP1 (LAMTOR2/3) complex regulates focal 
adhesion dynamics during cell migration. The Journal of cell biology 205, 525-540 (2014). 
73. Liu, L. et al. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-
BP1 pathways. Oncogene 25, 7029-7040 (2006). 
74. Pu, J., Guardia, C.M., Keren-Kaplan, T. & Bonifacino, J.S. Mechanisms and functions of 
lysosome positioning. J Cell Sci 129, 4329-4339 (2016). 
75. Kallunki, T., Olsen, O.D. & Jaattela, M. Cancer-associated lysosomal changes: friends or foes? 
Oncogene 32, 1995-2004 (2013). 
76. Bui, T. et al. Functional Redundancy between beta1 and beta3 Integrin in Activating the 
IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer. Cell Rep 29, 589-602 
e586 (2019). 
77. Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin 
insensitive. Nat Cell Biol 6, 1122-1128 (2004). 
78. Andrews, N.W. & Corrotte, M. Plasma membrane repair. Curr Biol 28, R392-R397 (2018). 
79. Reddy, A., Caler, E.V. & Andrews, N.W. Plasma membrane repair is mediated by Ca(2+)-
regulated exocytosis of lysosomes. Cell 106, 157-169 (2001). 
80. Coorssen, J.R., Schmitt, H. & Almers, W. Ca2+ triggers massive exocytosis in Chinese hamster 
ovary cells. The EMBO journal 15, 3787-3791 (1996). 
81. Riggi, M. et al. Decrease in plasma membrane tension triggers PtdIns(4,5)P2 phase 
separation to inactivate TORC2. Nat Cell Biol 20, 1043-1051 (2018). 
82. Cullen, P.J. & Steinberg, F. To degrade or not to degrade: mechanisms and significance of 
endocytic recycling. Nat Rev Mol Cell Biol 19, 679-696 (2018). 
83. Curnock, R., Calcagni, A., Ballabio, A. & Cullen, P.J. TFEB controls retromer expression in 
response to nutrient availability. J Cell Biol 218, 3954-3966 (2019). 
84. Kvainickas, A. et al. Retromer and TBC1D5 maintain late endosomal RAB7 domains to enable 
amino acid-induced mTORC1 signaling. J Cell Biol 218, 3019-3038 (2019). 
85. Nnah, I.C. et al. TFEB-driven endocytosis coordinates MTORC1 signaling and autophagy. 
Autophagy 15, 151-164 (2019). 
86. Bridges, D. et al. Rab5 proteins regulate activation and localization of target of rapamycin 
complex 1. J Biol Chem 287, 20913-20921 (2012). 
19 
 
87. Flinn, R.J., Yan, Y., Goswami, S., Parker, P.J. & Backer, J.M. The late endosome is essential for 
mTORC1 signaling. Mol Biol Cell 21, 833-841 (2010). 
88. Yuan, H.X., Russell, R.C. & Guan, K.L. Regulation of PIK3C3/VPS34 complexes by MTOR in 
nutrient stress-induced autophagy. Autophagy 9, 1983-1995 (2013). 
89. Munson, M.J. et al. mTOR activates the VPS34-UVRAG complex to regulate autolysosomal 
tubulation and cell survival. The EMBO journal 34, 2272-2290 (2015). 
90. Jahreiss, L., Menzies, F.M. & Rubinsztein, D.C. The itinerary of autophagosomes: from 
peripheral formation to kiss-and-run fusion with lysosomes. Traffic 9, 574-587 (2008). 
91. Mercer, T.J., Gubas, A. & Tooze, S.A. A molecular perspective of mammalian autophagosome 
biogenesis. J Biol Chem 293, 5386-5395 (2018). 
92. Di Malta, C. et al. Transcriptional activation of RagD GTPase controls mTORC1 and promotes 
cancer growth. Science 356, 1188-1192 (2017). 
93. Gosavi, P., Houghton, F.J., McMillan, P.J., Hanssen, E. & Gleeson, P.A. The Golgi ribbon in 
mammalian cells negatively regulates autophagy by modulating mTOR activity. J Cell Sci 131 
(2018). 
94. Fan, S.J. et al. PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 
from the Golgi and affect clinical outcome in colorectal cancer. Oncogene 35, 3004-3015 
(2016). 
95. Drenan, R.M., Liu, X., Bertram, P.G. & Zheng, X.F. FKBP12-rapamycin-associated protein or 
mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and 
the Golgi apparatus. J Biol Chem 279, 772-778 (2004). 
96. Thomas, J.D. et al. Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell 26, 
754-769 (2014). 
97. Castellano, B.M. et al. Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-
Pick C1 signaling complex. Science 355, 1306-1311 (2017). 
98. Sarkar, S. et al. Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 
disease. Cell Rep 5, 1302-1315 (2013). 
99. Lim, C.Y. et al. ER-lysosome contacts enable cholesterol sensing by mTORC1 and drive 
aberrant growth signalling in Niemann-Pick type C. Nat Cell Biol 21, 1206-1218 (2019). 
100. Rosner, M. & Hengstschlager, M. Cytoplasmic and nuclear distribution of the protein 
complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization 
of the mTORC2 components rictor and sin1. Hum Mol Genet 17, 2934-2948 (2008). 
101. Wan, W. et al. mTORC1 Phosphorylates Acetyltransferase p300 to Regulate Autophagy and 
Lipogenesis. Mol Cell 68, 323-335 e326 (2017). 
102. Kim, J.E. & Chen, J. Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is 
involved in rapamycin-sensitive signaling and translation initiation. Proc Natl Acad Sci U S A 
97, 14340-14345 (2000). 
103. Ahmed, A.R. et al. Direct imaging of the recruitment and phosphorylation of S6K1 in the 
mTORC1 pathway in living cells. Sci Rep 9, 3408 (2019). 
104. Zhang, X., Shu, L., Hosoi, H., Murti, K.G. & Houghton, P.J. Predominant nuclear localization of 
mammalian target of rapamycin in normal and malignant cells in culture. J Biol Chem 277, 
28127-28134 (2002). 
105. Tsang, C.K., Liu, H. & Zheng, X.F. mTOR binds to the promoters of RNA polymerase I- and III-
transcribed genes. Cell Cycle 9, 953-957 (2010). 
106. Audet-Walsh, E. et al. Nuclear mTOR acts as a transcriptional integrator of the androgen 
signaling pathway in prostate cancer. Genes Dev 31, 1228-1242 (2017). 
107. Napolitano, G. et al. mTOR-dependent phosphorylation controls TFEB nuclear export. Nat 
Commun 9, 3312 (2018). 
108. Li, L. et al. A TFEB nuclear export signal integrates amino acid supply and glucose availability. 
Nat Commun 9, 2685 (2018). 
20 
 
109. Harwood, F.C. et al. ETV7 is an essential component of a rapamycin-insensitive mTOR 
complex in cancer. Sci Adv 4, eaar3938 (2018). 
 

Figure 1: mTORC1 and the lysosome 
mTORC1 has been observed at various sites in the cell including the nucleus, cytoplasm and Golgi but 
it’s main site of activation is on the lysosome (also see Figure 2). mTORC1 is recruited to the lysosome 
via a complex including Rag GTPases, Ragulator, V-ATPase and SLC38A9 among others. The nutrient-
dependent re-localisation of mTORC1-positive lysosomes, along microtubules to the cell periphery 
may support mTORC1 activity by bringing it into close proximity with amino acids and growth factor 
signals at the plasma membrane. Starvation leads to the re-distribution of lysosomes to the 
juxtanuclear region where they are tethered to ER and Golgi membranes (see Figure 2). Clustering of 
lysosomes correlates with decreased mTORC1 and increased autophagy. 
The localisation of mTORC1 to the lysosomal membrane is dependent on the availability of amino 
acids which can derive from the extracellular environment or intracellular sources such as lysosomal 
degradation. Amino acid sensing has been noted in the cytoplasm, in the lysosome lumen and via 
poorly understood mechanisms via the Golgi (Figure 2). Recruitment of mTORC1 to the lysosome is 
widely considered to facilitate the direct interaction of mTORC1 with its activating small GTPase, Rheb. 
Rheb-GTP status is controlled downstream of growth factors and amino acids by the Rheb GAP, TSC 
complex (TSC1, TSC2 and TBC1D7). The localisation of Rheb is still a poorly understood area of mTORC1 
signalling, with reports placing the small GTPase at multiple sites including ER, Golgi and peroxisomes 
in addition to the lysosome (see Figure 2). Recent evidence suggests that Rheb localisation to the 
lysosome may be controlled via nucleotide-dependent interaction with PDEδ, a solubilising factor or 
via transient membrane interactions.  
The transcription factor, TFEB is an important regulator of the spatial control of mTORC1 via 
expression of mTORC1 regulators (e.g. RagD), autophagy and lysosomal genes and endosomal 
regulators such as components of the retromer complex, which facilitates the adaptive delivery of 
amino acid transporters from the Golgi to the cell surface in starvation.  
Figure 2: mTORC1 beyond the lysosome 
As well as the lysosomal surface, the cytoplasm, Golgi and nucleus have all been implicated in the 
regulation or activation of mTORC1. The Golgi has been particularly implicated in the transduction of 
amino acids such as glutamine via the small GTPase Arf1. More recently, Arf1 was also shown to be 
important for transducing the availability of asparagine while another Golgi localised small GTPase, 
Rab1a is further implicated in mTORC1 activation. Lysosomal-ER contact sites have been implicated in 
controlling mTORC1 activity via direct and indirect mechanisms, including the sensing of cholesterol, 
spatial association with autophagy and as the primary site for Rheb localisation.   

